✦ LIBER ✦

Polymorphisms ofCYP19A1and response to aromatase inhibitors in metastatic breast cancer patients

✍ Scribed by Roberta Ferraldeschi, Monica Arnedos, Kristen D. Hadfield, Roger A’Hern, Suzie Drury, Andrew Wardley, Anthony Howell, D. Gareth Evans, Stephen A. Roberts, Ian Smith, William G. Newman, Mitch Dowsett

Book ID: 113062452
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 295 KB
Volume: 133
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-2010-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Functional Genetic Polymorphisms in the

Functional Genetic Polymorphisms in the Aromatase Gene CYP19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy with Aromatase Inhibitors

✍ Ma, C.X.; Ellis, M.J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Aromatase inhibitors superior in metasta

Aromatase inhibitors superior in metastatic breast cancer?

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Association of functional polymorphisms

Association of functional polymorphisms inCYP19A1with aromatase inhibitor associated arthralgia in breast cancer survivors

✍ Jun J Mao; H Irene Su; Rui Feng; Michelle L Donelson; Richard Aplenc; Timothy R 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 436 KB

Fulvestrant in metastatic breast cancer

Fulvestrant in metastatic breast cancer previously treated with aromatase inhibitors

✍ J. Ribeiro; I. Luis; M. Fortunato; L. Correia; A. Quintela; P. Cortes; L. Costa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Switching to aromatase inhibitors in ear

Switching to aromatase inhibitors in early breast cancer

✍ Francesco Boccardo; Alessandra Rubagotti 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 53 KB

The role of aromatase inhibitors in the

The role of aromatase inhibitors in the treatment of metastatic breast cancer

✍ Henning Mouridsen; Michael Gershanovich 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 211 KB